Kronox Lab Sciences Share Price Target 2026 Analyst Forecast Bull and Bear Case

The Kronox Lab Sciences share price target 2026 is Rs 160, based on analyst estimates and the FY27 earnings recovery thesis for Kronox Lab Sciences (NSE: KRONOX). Q4 FY26 results released in 2026 are the immediate re-rating trigger. This article covers the complete Kronox Lab Sciences share price target analysis including sector tailwinds, peer context, key risks, and bull and bear case scenarios.

Click Here – Get Free Investment Predictions

Kronox Lab Sciences Share Price Target 2026: Key Takeaways

• Kronox Lab Sciences share price target 2026: Rs 160 (20% upside from CMP Rs 134.95)
• Bull case: Rs 195 | Bear case: Rs 110
• Ticker: KRONOX | Sector: Pharmaceutical Grade Solvents and Chemicals | MCap: Rs 202 crore
• 52W range: Rs 105 to Rs 240 | PE: 18x
• Key catalyst: Q4 FY26 results released in 2026 confirming FY27 earnings trajectory
• Key risk: FY27 earnings miss or sustained FII outflows from Indian equities

Kronox Lab Sciences Company Overview

Kronox Lab Sciences (NSE: KRONOX) is a Vadodara-based manufacturer of high-purity pharmaceutical grade solvents, specialty chemicals, and laboratory reagents for pharma formulation companies and research laboratories, listed in 2024. At CMP Rs 134.95 against a 52 week range of Rs 105 to Rs 240, the stock trades at a discount to its 52 week high. Market capitalisation is Rs 202 crore with trailing PE of 18x. Compared to peers in pharma chemicals like Balaji Amines and Sudarshan Chemical, Kronox Lab Sciences is positioned as a potential re-rating candidate toward the Kronox Lab Sciences share price target of Rs 160.

Parameter	Value
NSE Ticker	KRONOX
Sector	Pharmaceutical Grade Solvents and Chemicals
CMP (2026)	Rs 134.95
52 Week High	Rs 240
52 Week Low	Rs 105
Market Cap	Rs 202 crore
Trailing PE	18x
12-Month Analyst Target	Rs 160
Bull Case Target	Rs 195
Bear Case Target	Rs 110

Why Is the Kronox Lab Sciences Share Price Target Set at Rs 160 for 2026

FY27 Earnings Delivery and Revenue Acceleration

The Kronox Lab Sciences share price target 2026 of Rs 160 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings recovery trajectory are the most direct catalyst for re-rating from CMP Rs 134.95 toward Rs 160.

Structural Sector Tailwinds in Pharmaceutical Grade Solvents and Chemicals

The Pharmaceutical Grade Solvents and Chemicals sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising investment. Kronox Lab Sciences’s market position among peers in pharma chemicals like Balaji Amines and Sudarshan Chemical creates a structural growth runway supporting the Kronox Lab Sciences share price target of Rs 160 and bull case of Rs 195.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle in 2026 reduces Kronox Lab Sciences’s borrowing costs and stimulates end market demand. Lower interest costs improve the EPS trajectory, directly supporting the Kronox Lab Sciences share price target of Rs 160.

Union Budget 2026-27 Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a positive policy backdrop for Kronox Lab Sciences’s Pharmaceutical Grade Solvents and Chemicals operations, improving the probability of achieving the Kronox Lab Sciences share price target of Rs 160.

Improving FII Flows and Market Normalisation in 2026

As global macro conditions normalise through 2026, FII flows into quality Indian equities are recovering. At 18x PE, Kronox Lab Sciences is positioned as a beneficiary of institutional reallocation toward the Kronox Lab Sciences share price target of Rs 160.

Kronox Lab Sciences Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Kronox Lab Sciences Share Price Target

The near-term Kronox Lab Sciences share price target is anchored to support near the 52 week low of Rs 105. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating toward Rs 160.

12-Month Kronox Lab Sciences Share Price Target 2026

The 12-month Kronox Lab Sciences share price target 2026 is Rs 160, implying approximately 20 percent upside from CMP Rs 134.95. This base case assumes in-line FY27 earnings delivery and partial FII flow normalisation. Track live on NSE ticker KRONOX.

Long Term Kronox Lab Sciences Share Price Target: FY27 to FY28

For investors with a 2 to 3 year horizon, the long-term Kronox Lab Sciences share price target is Rs 195 in the bull case, assuming full earnings delivery and sector re-rating among peers in pharma chemicals like Balaji Amines and Sudarshan Chemical.

Bull Case and Bear Case for the Kronox Lab Sciences Share Price Target

Bull Case Kronox Lab Sciences Share Price Target: Rs 195

The bull case of Rs 195 materialises when FY27 earnings beat analyst estimates, Pharmaceutical Grade Solvents and Chemicals tailwinds accelerate, and FII flows return strongly, enabling re-rating toward higher peer multiples in 2026 and beyond.

Bear Case Kronox Lab Sciences Share Price Target: Rs 110

The bear case of Rs 110 materialises if FY27 earnings disappoint and FII outflows persist, with the stock approaching the 52 week low support of Rs 105.

Scenario	Target	Key Conditions
Bull Case	Rs 195	FY27 earnings beat, re-rating, FII inflows
Base Case	Rs 160	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 110	FY27 miss, guidance cut, FII outflows

Key Risks to the Kronox Lab Sciences Share Price Target 2026

Global Macro and Tariff Risk

Global tariff tensions and macro headwinds remain a key risk to the Kronox Lab Sciences share price target 2026 of Rs 160, with FII outflows a direct consequence of sustained geopolitical uncertainty.

Valuation and Earnings Miss Risk

Any FY27 earnings miss or guidance cut could compress multiples, posing the most direct risk to the Kronox Lab Sciences share price target of Rs 160.

Competitive Pressure in Pharmaceutical Grade Solvents and Chemicals

Intensifying competition among peers in pharma chemicals like Balaji Amines and Sudarshan Chemical could compress Kronox Lab Sciences’s pricing power, a structural risk that must be factored into any assessment of the Kronox Lab Sciences share price target of Rs 160.

FII Selling and Liquidity Risk

Sustained FII outflows from Indian equities can delay re-rating toward the Kronox Lab Sciences share price target of Rs 160 regardless of company-level improvement through FY27.

How to Invest in Kronox Lab Sciences

Check the Univest Screener for live data

Begin by reviewing Kronox Lab Sciences’s Q4 FY26 results, annual report, and FY27 guidance released in 2026 before forming a view on the Kronox Lab Sciences share price target of Rs 160. Focus on revenue growth, margin trends, and management commentary on Pharmaceutical Grade Solvents and Chemicals sector opportunities.

Open a Demat and trading account with a SEBI registered stockbroker to buy Kronox Lab Sciences (NSE: KRONOX) with full regulatory protection. Understand the competitive dynamics among peers in pharma chemicals like Balaji Amines and Sudarshan Chemical before executing any position.

Plan your entry near the 52 week low support of Rs 105. A confirmed FY27 earnings uptick would strengthen the entry case for the Kronox Lab Sciences share price target of Rs 160. Set a disciplined stop loss below the 52 week low.

Restrict any single stock to 3 to 5 percent of your total equity portfolio to manage concentration risk, especially in the Pharmaceutical Grade Solvents and Chemicals space where sectoral cycles can amplify volatility.

Always consult a SEBI registered financial advisor before investing based on any Kronox Lab Sciences share price target estimate. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Kronox Lab Sciences’s live price and get daily stock recommendations.

FAQs on Kronox Lab Sciences Share Price Target 2026

What is the Kronox Lab Sciences share price target for 2026?

Ans. The Kronox Lab Sciences share price target 2026 is Rs 160, implying approximately 20 percent upside from CMP Rs 134.95. Bull case is Rs 195 and bear case is Rs 110.

What is the Kronox Lab Sciences share price target for 2025?

Ans. The Kronox Lab Sciences share price target for 2025 was based on FY26 earnings projections. The current 2026 analyst target is Rs 160, reflecting FY27 growth potential from CMP Rs 134.95.

Is Kronox Lab Sciences a good buy at Rs 134.95?

Ans. At Rs 134.95, Kronox Lab Sciences offers potential upside to the share price target of Rs 160 if FY27 earnings recover as projected. Consult a SEBI registered financial advisor before investing.

What is the 52 week high and low of Kronox Lab Sciences?

Ans. The 52 week high of Kronox Lab Sciences is Rs 240 and the 52 week low is Rs 105. At CMP Rs 134.95, the stock offers upside potential toward the 12-month share price target of Rs 160.

What are the key risks to the Kronox Lab Sciences share price target?

Ans. Key risks include FY27 earnings miss, US tariff-driven FII outflows, competitive pressure among peers in pharma chemicals like Balaji Amines and Sudarshan Chemical, and broader market volatility impacting Indian equities in 2026.

What are the catalysts for the Kronox Lab Sciences share price target?

Ans. Primary catalysts include FY27 PAT recovery, Pharmaceutical Grade Solvents and Chemicals sector tailwinds, RBI rate cut support in 2026, Union Budget 2026-27 policy uplift, and normalisation of FII flows into Indian equities.

How does Kronox Lab Sciences compare to its peers?

Ans. Kronox Lab Sciences operates in Pharmaceutical Grade Solvents and Chemicals alongside peers in pharma chemicals like Balaji Amines and Sudarshan Chemical. At CMP Rs 134.95 with MCap Rs 202 crore, the company is a potential re-rating candidate toward the share price target of Rs 160 on FY27 earnings delivery.

What is the Kronox Lab Sciences share price target for 2027?

Ans. The long-term Kronox Lab Sciences share price target for FY27 to FY28 is Rs 195 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows. Consult a SEBI registered financial advisor for personalised guidance.